AAAAAA

   
Results: 1-8 |
Results: 8
THE EFFECT OF PLASMA DRUG CONCENTRATIONS ON HIV-1 CLEARANCE RATE DURING QUADRUPLE DRUG-THERAPY
Authors: HOETELMANS RMW REIJERS MHE WEVERLING GJ TENKATE RW WIT FWNM MULDER JW WEIGEL HM FRISSEN PHJ ROOS M JURRIAANS S SCHUITEMAKER H DEWOLF F BEIJNEN JH LANGE JMA
Citation: Rmw. Hoetelmans et al., THE EFFECT OF PLASMA DRUG CONCENTRATIONS ON HIV-1 CLEARANCE RATE DURING QUADRUPLE DRUG-THERAPY, AIDS, 12(11), 1998, pp. 111-115
MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY
Authors: REIJERS MHE WEVERLING GJ JURRIAANS S WIT FWNM WEIGEL HM TENKATE RW MULDER JW FRISSEN PHJ VANLEEUWEN R REISS P SCHUITEMAKER H DEWOLF F LANGE JMA
Citation: Mhe. Reijers et al., MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY, Lancet, 352(9123), 1998, pp. 185-190
17-ALPHA-HYDROXYLASE DEFICIENCY - A RARE CAUSE OF CHRONIC HYPERTENSION
Authors: SPRONK PE BERGKAMP F TENKATE RW
Citation: Pe. Spronk et al., 17-ALPHA-HYDROXYLASE DEFICIENCY - A RARE CAUSE OF CHRONIC HYPERTENSION, Netherlands journal of medicine, 49(5), 1996, pp. 205-208
ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/
Authors: FERNANDEZCRUZ E LANG JM FRISSEN J FURNER V CHATEAUVERT M BOUCHER CAB DOWD P STEVENS J GOLD J MICHELMORE H BENSON E SPELMAN E HOY J WRIGHT E FRENCH M HUDSON J MALLAL S BODSWORTH N STINGL G MAYERHOFER S KRONAWETTER M TSOUKAS C SZABO T KATLAMA C GUERMONPREZ G RAFFI F BILLAUD E MILPIED B BOURGEOT V FLEISHMANN M BARRIER JH DELZANT G WINTER C MEHARZI J TREPO C COTTE L ROUGIER P HASSAIRI N CHOUTET P BESNIER JM LAFEUILLADE A RASOKAT H GROSS G MAUSCH HE STRATIGOS J POLYDOROV D STAVRIANEAS N KIOSSES V MANDALAKI T KARAFOULIDOU A KARABINIS A STERGIOU G PLOUMIDES G PITSAS A TASSOPOULOS N KOUTSOUNOPOULOS G HATZAKIS A MORONI M DARMINIO A BINI T CHIODO F COLANGELI V RICCHI E AIUTI F FERRARA R MEZZAROMA I LANGE JMA FRISSEN PHJ SPRENGER HG KROON FP VANDERENDE ME DEMARIE S KOOPMANS PP DOLMANS WMV SCHREIJ GS WEIGEL HM TENNAPEL CHH TENKATE RW MARANON G ZABAY JM COSIN J PENA JM RUBIO R RIBERA E VAZQUEZ JMM LEAL M ANDREU J CARTON JA ASENSI V GOMEZTRUJILLO F ORIHUELA F SERRANO C FERRER E MANDAL BK JOHNSON M MCKARTHY K FARMER D TANG A MITCHELL SA BROWN J TOORAWA R YEO J
Citation: E. Fernandezcruz et al., ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/, AIDS, 9(9), 1995, pp. 1025-1035
EFFICACY AND TOXICITY OF 2 DOSES OF TRIMETHOPRIM-SULFAMETHOXAZOLE AS PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTSWITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: SCHNEIDER MME NIELSEN TL NELSING S HOEPELMAN AIM SCHATTENKERK JKME VANDERGRAAF Y KOLSTERS AFP BORLEFFS JCC DANNER SA VANLEEUWEN R FRISSEN JPHJ WEIGEL HM VANDERENDE IME SPRENGER HG KAUFFMANN RH KROON F MEENHORST PL TENNAPEL CHH SCHREIJ G TENKATE RW JUTTMANN JR KOOPMANS PP
Citation: Mme. Schneider et al., EFFICACY AND TOXICITY OF 2 DOSES OF TRIMETHOPRIM-SULFAMETHOXAZOLE AS PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTSWITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infectious diseases, 171(6), 1995, pp. 1632-1636
THE RENAL HANDLING OF PEPSINOGEN-A ISOZYMOGENS IN MAN
Authors: ZWIERS A TENDAM MAGJ CRUSIUS JBA WERTER CJPJ PALS G DONKER AJM MEUWISSEN SGM TENKATE RW
Citation: A. Zwiers et al., THE RENAL HANDLING OF PEPSINOGEN-A ISOZYMOGENS IN MAN, Clinical nephrology, 41(3), 1994, pp. 153-158
MICROTITER ENZYME-LINKED-IMMUNOSORBENT-ASSAY USING RECOMBINANT-DERIVED ANTIGENS VERSUS WESTERN-BLOT IN THE CONFIRMATION OF PRESENCE OF ANTIBODIES AGAINST THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: ROOSENDAAL R VANKAMP GJ MULDER C CALLIAUW J KEMPERS J DIRKS M WOLTERS EC TENKATE RW
Citation: R. Roosendaal et al., MICROTITER ENZYME-LINKED-IMMUNOSORBENT-ASSAY USING RECOMBINANT-DERIVED ANTIGENS VERSUS WESTERN-BLOT IN THE CONFIRMATION OF PRESENCE OF ANTIBODIES AGAINST THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virological methods, 44(2-3), 1993, pp. 271-280
THE CONCORDE TRIAL
Authors: DANNER SA SCHATTENKERK JKME LOELIGER AE VANDERMEER JTM REISS P HENRICHS JM FRISSEN PHJ WEIGEL HM MULDER JW MEENHORST PL VANDERWOLF MGB TENVEEN JH CLAESSEN FAP VEENSTRA J BORLEFFS JCC HOEPELMAN IM SCHNEIDER ME DEMARIE S VANDERENDE ME VOETS W KAUFFMANN RH KROON FP JUTTMAN JR FOLMER SCCR FERWERDA J TENKATE RW VANLEUSEN R VREDEN SGS PERENBOOM R SPRENGER HG TENNAPEL CHH
Citation: Sa. Danner et al., THE CONCORDE TRIAL, Lancet, 341(8855), 1993, pp. 1276-1276
Risultati: 1-8 |